170

Hepatobiliary&Pancreas Surgery
Focuses on the health of liver, bile, and pancreatic organs.
Sub Categories on Hepatobiliary&Pancreas Surgery
Latest Articles
Multiple myeloma cured after hepatitis treatment reveals that this cancer can be caused by viruses

Multiple myeloma cured after hepatitis treatment reveals that this cancer can be caused by viruses

JANUARY 19, 2024byThe Spanish National Cancer Research CentreThe effect of antiviral treatment in hepatitis C virus- and hepatitis B virus-infected multiple myeloma cohorts. (A) Study design and

Multiple myeloma cured after hepatitis treatment reveals that this cancer can be caused by viruses

JANUARY 19, 2024byThe Spanish National Cancer Research CentreThe effect of antiviral treatment in hepatitis C virus- and hepatitis B virus-infected multiple myeloma cohorts. (A) Study design and
Using social determinants of health to guide liver disease screening

Using social determinants of health to guide liver disease screening

by Ariana Baldassano,Rush University Medical CenterCredit:JHEP Reports(2023). DOI: 10.1016/j.jhepr.2023.100696Black people face a higher risk of developing severe liver fibrosis, but

Using social determinants of health to guide liver disease screening

by Ariana Baldassano,Rush University Medical CenterCredit:JHEP Reports(2023). DOI: 10.1016/j.jhepr.2023.100696Black people face a higher risk of developing severe liver fibrosis, but
New combination therapy offers chance of healing hepatitis B

New combination therapy offers chance of healing hepatitis B

by German Center for Infection ResearchThe digitally-colorized transmission electron microscopic image reveals the presence of Hepatitis B virions (orange colored). Credit: CDC/Dr. Erskine PalmerAroun

New combination therapy offers chance of healing hepatitis B

by German Center for Infection ResearchThe digitally-colorized transmission electron microscopic image reveals the presence of Hepatitis B virions (orange colored). Credit: CDC/Dr. Erskine PalmerAroun
Bacterial agent opens new therapeutic options for Wilson's disease

Bacterial agent opens new therapeutic options for Wilson's disease

by Helmholtz Association of German Research CentresGraphical abstract. Credit:Gastroenterology(2023). DOI: 10.1053/j.gastro.2023.03.216A specific molecule excreted by methane-oxidizin

Bacterial agent opens new therapeutic options for Wilson's disease

by Helmholtz Association of German Research CentresGraphical abstract. Credit:Gastroenterology(2023). DOI: 10.1053/j.gastro.2023.03.216A specific molecule excreted by methane-oxidizin
Hepatitis C virus infection: Research team discovers that a protein has an unexpected proviral effect

Hepatitis C virus infection: Research team discovers that a protein has an unexpected proviral effect

by Susanne Stöcker, Paul-Ehrlich-Institut - Bundesinstitut für Impfstoffe und biomedizinische ArzneimittelThe expression of GBP1 is increased in HCV replicating cells. Credit:PLOS Pathogens&nbsp

Hepatitis C virus infection: Research team discovers that a protein has an unexpected proviral effect

by Susanne Stöcker, Paul-Ehrlich-Institut - Bundesinstitut für Impfstoffe und biomedizinische ArzneimittelThe expression of GBP1 is increased in HCV replicating cells. Credit:PLOS Pathogens&nbsp
Exposure to toxic blue-green algae, exacerbated by climate change, shown to cause liver disease in mouse models

Exposure to toxic blue-green algae, exacerbated by climate change, shown to cause liver disease in mouse models

by University of California, IrvineCYN exposure in mice for 15 days via oral gavage caused an altered gut bacteriome pattern at both phylum and family levels with decreased α-diversity. (A) The r

Exposure to toxic blue-green algae, exacerbated by climate change, shown to cause liver disease in mouse models

by University of California, IrvineCYN exposure in mice for 15 days via oral gavage caused an altered gut bacteriome pattern at both phylum and family levels with decreased α-diversity. (A) The r
Markers of inflammation can predict 180-day mortality in cirrhosis

Markers of inflammation can predict 180-day mortality in cirrhosis

by Elana GotkineFor patients with newly diagnosed cirrhosis, markers of inflammation can predict 180-day mortality, but not liver-related admissions, according to a study published online Nov. 16 in&n

Markers of inflammation can predict 180-day mortality in cirrhosis

by Elana GotkineFor patients with newly diagnosed cirrhosis, markers of inflammation can predict 180-day mortality, but not liver-related admissions, according to a study published online Nov. 16 in&n
Cytoglobin: Key player in preventing liver disease

Cytoglobin: Key player in preventing liver disease

by Osaka City University6His tagged recombinant human CYGB (His-CYGB) was endocytosed into the HSCs via Clathrin-mediated pathway, scavenged ROS, such as O2- and OH-, and induced IFN-β secretion media

Cytoglobin: Key player in preventing liver disease

by Osaka City University6His tagged recombinant human CYGB (His-CYGB) was endocytosed into the HSCs via Clathrin-mediated pathway, scavenged ROS, such as O2- and OH-, and induced IFN-β secretion media
Team performs the first gene therapy tests in a whole human liver

Team performs the first gene therapy tests in a whole human liver

by Children's Medical Research InstituteCredit: Pixabay/CC0 Public DomainIn a worldwide first-of-its-kind study published in the journalNature Communicationsthis week, a team of scient

Team performs the first gene therapy tests in a whole human liver

by Children's Medical Research InstituteCredit: Pixabay/CC0 Public DomainIn a worldwide first-of-its-kind study published in the journalNature Communicationsthis week, a team of scient
Study ties diabetes and obesity to increased risk of liver cancer relapse

Study ties diabetes and obesity to increased risk of liver cancer relapse

byOsaka Metropolitan UniversityDiabetes mellitus and obesity are risks for late postoperative recurrence of hepatocellular carcinoma. Credit: Osaka Metropolitan UniversityHepatocellular carcinom

Study ties diabetes and obesity to increased risk of liver cancer relapse

byOsaka Metropolitan UniversityDiabetes mellitus and obesity are risks for late postoperative recurrence of hepatocellular carcinoma. Credit: Osaka Metropolitan UniversityHepatocellular carcinom